In the latest session, Outset Medical Inc (NASDAQ: OM) closed at $1.99 down -4.78% from its previous closing price of $2.09. In other words, the price has decreased by -$0.1000 from its previous closing price. On the day, 965907 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Outset Medical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.37 and its Current Ratio is at 5.26. In the meantime, Its Debt-to-Equity ratio is 1.11 whereas as Long-Term Debt/Eq ratio is at 1.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on January 12, 2024, Downgraded its rating to Sector Perform and sets its target price to $6 from $14 previously.
On October 13, 2023, BofA Securities Downgraded its rating to Underperform which previously was Buy and also lowered its target price recommendation from $32 to $3.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 15 ’24 when Nash Marc sold 2,391 shares for $2.13 per share. The transaction valued at 5,093 led to the insider holds 242,510 shares of the business.
Ahmed Nabeel sold 1,584 shares of OM for $4,990 on Mar 01 ’24. The Chief Financial Officer now owns 322,877 shares after completing the transaction at $3.15 per share. On Feb 15 ’24, another insider, Trigg Leslie, who serves as the Chair and CEO of the company, sold 5,320 shares for $3.57 each. As a result, the insider received 18,992 and left with 833,091 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 100.51M and an Enterprise Value of 33.37M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.77 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at 0.26 whereas that against EBITDA is -0.22.
Stock Price History:
Over the past 52 weeks, OM has reached a high of $24.13, while it has fallen to a 52-week low of $1.98. The 50-Day Moving Average of the stock is 3.1855, while the 200-Day Moving Average is calculated to be 9.5483.
Shares Statistics:
For the past three months, OM has traded an average of 1.04M shares per day and 1.09M over the past ten days. A total of 50.32M shares are outstanding, with a floating share count of 46.36M. Insiders hold about 8.20% of the company’s shares, while institutions hold 105.24% stake in the company. Shares short for OM as of Feb 29, 2024 were 8.09M with a Short Ratio of 7.81, compared to 8.32M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.01% and a Short% of Float of 18.84%.
Earnings Estimates
There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.54 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.62, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.46 and low estimates of -$0.59.
Analysts are recommending an EPS of between -$1.95 and -$2.18 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$1.8, with 6 analysts recommending between -$1.65 and -$1.99.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $30.45M this quarter.It ranges from a high estimate of $31M to a low estimate of $29.6M. As of the current estimate, Outset Medical Inc’s year-ago sales were $31.76M, an estimated decrease of -4.10% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $33.71M, a decrease of -6.50% less than the figure of -$4.10% in the same quarter last year. There is a high estimate of $35.8M for the next quarter, whereas the lowest estimate is $32M.
A total of 7 analysts have provided revenue estimates for OM’s current fiscal year. The highest revenue estimate was $150.1M, while the lowest revenue estimate was $145.73M, resulting in an average revenue estimate of $148.42M. In the same quarter a year ago, actual revenue was $130.38M, up 13.80% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $173.92M in the next fiscal year. The high estimate is $179M and the low estimate is $165.7M. The average revenue growth estimate for next year is up 17.20% from the average revenue estimate for this year.
